Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of FRD001 Injection in Ultrasound Contrast Imaging for the Differential Diagnosis of Benign and Malignant Ovarian Masses in Women

NCT06556342 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06556342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06556342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of FRD001 Injection in Ultrasound Contrast Imaging for the Differential Diagnosis of Benign and Malignant Ovarian Masses in Women
Lead sponsor
Tongji Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2024
Completion date
July 1, 2028
Enrollment
198 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovary cancer